Northern Financial Advisors Inc Lowers Holdings in Colgate-Palmolive (NYSE:CL)

Northern Financial Advisors Inc trimmed its position in shares of Colgate-Palmolive (NYSE:CLFree Report) by 14.6% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 5,840 shares of the company’s stock after selling 1,002 shares during the quarter. Northern Financial Advisors Inc’s holdings in Colgate-Palmolive were worth $531,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Asset Management One Co. Ltd. grew its holdings in shares of Colgate-Palmolive by 4.3% during the fourth quarter. Asset Management One Co. Ltd. now owns 392,938 shares of the company’s stock valued at $36,076,000 after buying an additional 16,036 shares during the last quarter. Avestar Capital LLC lifted its position in Colgate-Palmolive by 14.4% in the 4th quarter. Avestar Capital LLC now owns 5,142 shares of the company’s stock valued at $467,000 after acquiring an additional 649 shares in the last quarter. Ingalls & Snyder LLC boosted its stake in Colgate-Palmolive by 1.2% during the 4th quarter. Ingalls & Snyder LLC now owns 23,557 shares of the company’s stock valued at $2,142,000 after purchasing an additional 282 shares during the last quarter. McClarren Financial Advisors Inc. purchased a new position in shares of Colgate-Palmolive in the fourth quarter worth $55,000. Finally, Retirement Guys Formula LLC raised its stake in shares of Colgate-Palmolive by 15.3% in the fourth quarter. Retirement Guys Formula LLC now owns 8,463 shares of the company’s stock worth $769,000 after purchasing an additional 1,125 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research firms recently commented on CL. Royal Bank of Canada reiterated a “sector perform” rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a report on Wednesday, January 29th. UBS Group reduced their price target on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research note on Monday, February 3rd. JPMorgan Chase & Co. decreased their price objective on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a report on Monday, February 3rd. Morgan Stanley dropped their target price on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a report on Monday, February 3rd. Finally, TD Cowen decreased their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $101.16.

Read Our Latest Report on CL

Colgate-Palmolive Stock Up 1.3 %

Shares of CL stock opened at $87.87 on Friday. The company has a debt-to-equity ratio of 9.46, a current ratio of 0.41 and a quick ratio of 0.26. Colgate-Palmolive has a one year low of $82.83 and a one year high of $109.30. The company’s fifty day moving average price is $89.83 and its 200-day moving average price is $96.54. The company has a market capitalization of $71.79 billion, a price-to-earnings ratio of 24.96, a PEG ratio of 4.12 and a beta of 0.44.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the previous year, the firm earned $0.87 EPS. Sell-side analysts expect that Colgate-Palmolive will post 3.73 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.28%. Colgate-Palmolive’s payout ratio is 56.82%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.